Company intelligence / Profile preview

TômTex

Brooklyn, New York, USAtomtex.com ↗

Ownership: Private
Development stage: Commercial

Overview

TômTex has developed a scalable process to create biodegradable, plastic-free "bioleather" from food waste such as seafood shells and coffee grounds. The material uses chitosan—a biopolymer from seafood shells and mushrooms—processed with green chemistry to form durable leather-like textiles. The company has raised $4.15 million in funding to expand manufacturing at its Brooklyn facility and scale production for commercial contracts. No clinical results as the company does not operate in drug development.

Industry: Non-Drug Biotech

Partnerships

Happiness CapitalSOSV/IndieBioParley for the OceansMIH Capital

Beyond the preview

Go deeper on TômTex.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TômTex.

Explore the full profile